Jump to content

3C-BZ

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Mario Castelán Castro (talk | contribs) at 02:36, 28 August 2016. The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

3C-BZ
Names
IUPAC name
1-(4-benzyloxy-3,5-methoxyphenyl)propan-2-amine
Other names
4-Benzyloxy-3,5-methoxyamphetamine
Identifiers
3D model (JSmol)
ChEMBL
ChemSpider
  • InChI=1S/C18H23NO3/c1-13(19)9-15-10-16(20-2)18(17(11-15)21-3)22-12-14-7-5-4-6-8-14/h4-8,10-11,13H,9,12,19H2,1-3H3 checkY
    Key: IQKPLBJGFPDASR-UHFFFAOYSA-N checkY
  • InChI=1/C18H23NO3/c1-13(19)9-15-10-16(20-2)18(17(11-15)21-3)22-12-14-7-5-4-6-8-14/h4-8,10-11,13H,9,12,19H2,1-3H3
    Key: IQKPLBJGFPDASR-UHFFFAOYAD
  • CC(N)Cc2cc(OC)c(OCc1ccccc1)c(c2)OC
Properties
C18H23NO3
Molar mass 301.39 g/mol
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
☒N verify (what is checkY☒N ?)

3C-BZ, or 4-benzyloxy-3,5-dimethoxyamphetamine, is a lesser-known psychedelic drug and a substituted amphetamine. 3C-BZ was first synthesized by Alexander Shulgin. In his book PiHKAL, the dosage range is listed as 25–200 mg, and the duration as 18–24 hours. According to anecdotal reports from the substance's entry in PiHKAL, 3C-BZ's effects can vary significantly, ranging from intensified emotions and strange dreams, to effects similar to those of LSD or TMA.[1] Very little data exists about the pharmacological properties, metabolism, and toxicity of 3C-BZ.

References

  1. ^ Shulgin, Alexander; Shulgin, Ann (September 1991). PiHKAL: A Chemical Love Story. Berkeley, California: Transform Press. ISBN 0-9630096-0-5. OCLC 25627628.

Template:PiHKAL